| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-247 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-24 |
| filingDate |
2001-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f881be7d0bb20ba0d618e6f3c2da585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47aa8850aa9f45e255c7b4320251cc2a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a15167c3bd3f19ccfd5e7c8527ef61d |
| publicationDate |
2003-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2003028042-A1 |
| titleOfInvention |
Il8-receptor antagonists |
| abstract |
This invention relates to the novel use of diphenyl phosphonates in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007249672-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009093451-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009093492-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7893089-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009281110-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007249625-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009170871-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7709485-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8097626-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011105563-A1 |
| priorityDate |
2002-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |